eric deutsch
eric deutsch
Adresse e-mail validée de
Citée par
Citée par
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
Autophagy 12 (1), 1-222, 2016
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
B Routy, E Le Chatelier, L Derosa, CPM Duong, MT Alou, R Daillère, ...
Science 359 (6371), 91-97, 2018
Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway—therapeutic perspectives in cancer
Y Tao, V Pinzi, J Bourhis, E Deutsch
Nature clinical practice Oncology 4 (10), 591-602, 2007
High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: results of the MOSCATO 01 trial
C Massard, S Michiels, C Ferté, MC Le Deley, L Lacroix, A Hollebecque, ...
Cancer discovery 7 (6), 586-595, 2017
Identifying the best machine learning algorithms for brain tumor segmentation, progression assessment, and overall survival prediction in the BRATS challenge
S Bakas, M Reyes, A Jakab, S Bauer, M Rempfler, A Crimi, RT Shinohara, ...
arXiv preprint arXiv:1811.02629, 2018
Tumour stem cell-targeted treatment: elimination or differentiation
C Massard, E Deutsch, JC Soria
Annals of oncology 17 (11), 1620-1624, 2006
Nanoscale radiotherapy with hafnium oxide nanoparticles
L Maggiorella, G Barouch, C Devaux, A Pottier, E Deutsch, J Bourhis, ...
Future oncology 8 (9), 1167-1181, 2012
BCR-ABL down-regulates the DNA repair protein DNA-PKcs
E Deutsch, A Dugray, B AbdulKarim, E Marangoni, L Maggiorella, ...
Blood, The Journal of the American Society of Hematology 97 (7), 2084-2090, 2001
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
R Sun, EJ Limkin, M Vakalopoulou, L Dercle, S Champiat, SR Han, ...
The Lancet Oncology 19 (9), 1180-1191, 2018
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
EJ Limkin, R Sun, L Dercle, EI Zacharaki, C Robert, S Reuzé, ...
Annals of Oncology 28 (6), 1191-1206, 2017
Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers
B Abdulkarim, S Sabri, E Deutsch, H Chagraoui, L Maggiorella, J Thierry, ...
Oncogene 21 (15), 2334-2346, 2002
Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling
A Ko, A Kanehisa, I Martins, L Senovilla, C Chargari, D Dugue, G Marino, ...
Cell Death & Differentiation 21 (1), 92-99, 2014
Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages
F Milliat, A François, M Isoir, E Deutsch, R Tamarat, G Tarlet, A Atfi, ...
The American journal of pathology 169 (4), 1484-1495, 2006
Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity
R Prevo, E Deutsch, O Sampson, J Diplexcito, K Cengel, J Harper, ...
Cancer research 68 (14), 5915-5923, 2008
A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma
J Bourhis, R De Crevoisier, B Abdulkarim, E Deutsch, A Lusinchi, ...
International Journal of Radiation Oncology* Biology* Physics 46 (5), 1105-1108, 2000
Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells
B Wen, E Deutsch, E Marangoni, V Frascona, L Maggiorella, ...
British journal of cancer 85 (12), 2017-2021, 2001
The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy
L Sancey, F Lux, S Kotb, S Roux, S Dufort, A Bianchi, Y Cremillieux, ...
The British journal of radiology 87 (1041), 20140134, 2014
Down-regulation of BRCA1 in BCR-ABL–expressing hematopoietic cells
E Deutsch, S Jarrousse, D Buet, A Dugray, ML Bonnet, ...
Blood 101 (11), 4583-4588, 2003
Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion
A Kaliski, L Maggiorella, KA Cengel, D Mathe, V Rouffiac, P Opolon, ...
Molecular cancer therapeutics 4 (11), 1717-1728, 2005
Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy
Y Loriot, G Perlemuter, D Malka, F Penault-Lorca, V Boige, E Deutsch, ...
Nature clinical practice Oncology 5 (5), 268-278, 2008
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20